Founders Financial Securities LLC Lowers Stock Position in The Procter & Gamble Company (NYSE:PG)

Founders Financial Securities LLC trimmed its stake in shares of The Procter & Gamble Company (NYSE:PG) by 1.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,963 shares of the company’s stock after selling 415 shares during the period. Founders Financial Securities LLC’s holdings in Procter & Gamble were worth $3,888,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Advantage Trust Co purchased a new position in shares of Procter & Gamble in the fourth quarter worth about $28,000. Naples Money Management LLC acquired a new stake in Procter & Gamble during the fourth quarter worth about $29,000. Wyrmwood Management LLC acquired a new stake in Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC acquired a new stake in Procter & Gamble during the fourth quarter worth about $31,000. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Procter & Gamble during the fourth quarter worth about $33,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 855 shares of the business’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total transaction of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at approximately $634,634. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now directly owns 11,507 shares in the company, valued at $1,858,265.43. The disclosure for this sale can be found here. In the last three months, insiders have sold 154,544 shares of company stock valued at $25,413,051. 0.17% of the stock is owned by company insiders.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded down $1.70 during trading on Friday, reaching $164.92. The company’s stock had a trading volume of 9,253,317 shares, compared to its average volume of 6,088,934. The company has a 50-day moving average price of $165.60 and a two-hundred day moving average price of $158.81. The firm has a market cap of $389.23 billion, a PE ratio of 26.95, a P/E/G ratio of 3.35 and a beta of 0.42. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $169.41. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 EPS. On average, analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were paid a $1.0065 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s payout ratio is currently 65.85%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on PG shares. Barclays raised their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Argus lifted their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, April 25th. StockNews.com upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Tuesday, June 25th. Finally, BNP Paribas assumed coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $170.72.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.